Steigerwald, Gordon & Koch Inc. Ligand Pharmaceuticals Inc Transaction History

Steigerwald, Gordon & Koch Inc.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 25, 2022	SELL	$94.99 - $151.56 $148,754 - $237,342	-1,566 Closed	0 $0
Q1 2021 Apr 27, 2021	BUY	$99.52 - $215.83 $155,848 - $337,989	1,566 New	1,566 $239,000
Q1 2019 Apr 18, 2019	SELL	$105.93 - $142.47 $165,886 - $223,108	-1,566 Closed	0 $0
Q2 2018 Sep 14, 2018	BUY	$150.77 - $207.98 $236,105 - $325,696	1,566 New	1,566 $324,000
Q1 2018 Sep 14, 2018	SELL	$138.63 - $182.62 $217,094 - $285,982	-1,566 Closed	0 $0
Q4 2017 Sep 14, 2018	BUY	$128.36 - $147.04 $201,011 - $230,264	1,566 New	1,566 $214,000
Q3 2017 Sep 14, 2018	SELL	$120.91 - $137.94 $201,436 - $229,808	-1,666 Closed	0 $0
Q2 2017 Sep 13, 2018	BUY	N/A	1,666 New	1,666 $202,000
Q4 2016 Sep 13, 2018	SELL	N/A	-1,998 Closed	0 $0
Q4 2015 Sep 13, 2018	BUY	N/A	1,998 New	1,998 $217,000
Q2 2015 Sep 13, 2018	SELL	N/A	-10,530 Closed	0 $0
Q1 2015 Sep 13, 2018	BUY	N/A	10,530	10,530 $328,000

257

18.2M

26.8K

9.3K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.88B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Steigerwald, Gordon & Koch Inc., based on Form 13F filings with the SEC.

Stay updated on Steigerwald, Gordon & Koch Inc. with notifications on news.